Preview Mode Links will not work in preview mode

Substantial Matters: Life & Science of Parkinson’s

Dec 19, 2017

People with Parkinson’s disease (PD) are two times as likely to fall as other people their age. And while healthcare professionals recognize the extent of the problem, there is still a lot to learn about why they happen and what can be done to prevent them. Dr. Sotirios Parashos, Director of Research at the...


Dec 5, 2017

Stem cells – those cells that can give rise to so many cell types in the body – have been touted as the cure-all for a variety of diseases, including Parkinson’s. But to date, attempts at stem cell transplantation into the brain have fallen short. Parkinson’s is one of the most complex diseases, with a variety...


Nov 21, 2017

Alpha-synuclein is a protein in the human brain that is linked with the development of Parkinson’s disease. An important scientific paper came out in September 2017 describing how some common drugs, already approved by the Food and Drug Administration for other purposes, may lower the production of alpha-synuclein...


Nov 7, 2017

Clinical trials – research studies that involve people – are key to medical advances. But sometimes it is hard to recruit and enroll enough participants to make the results meaningful. It is important for people with Parkinson’s disease to participate in clinical trials to help researchers find better ways to...


Oct 24, 2017

Therapies are available to treat Parkinson’s symptoms and improve quality of life for people living with the disease. But we don’t yet have a way to slow or stop Parkinson’s progression, and that is why research is critical. Dr. Tanya Simuni of the Parkinson’s Foundation Center of Excellence at...